期刊文献+

L - 精氨酸基姜黄素衍生物的合成及抑菌性评价 被引量:5

Synthesis and antibacterial evaluation of L-arginine curcumin derivative
下载PDF
导出
摘要 以4-二甲氨基吡啶(DMAP)为催化剂,1-(3-二甲氨基丙基)-3-乙基碳二亚胺(EDC)为脱水剂,琥珀酸(Sa)为连接臂,通过酯化和酰胺化反应将姜黄素接枝到L-精氨酸分子上,获得新型L-精氨酸基姜黄素(Cur-Sa-Arg)衍生物,产物经UV-Vis、FT-IR、1H NMR和DSC表征,证明已成功合成.与姜黄素相比,Cur-Sa-Arg在水中的溶解度增大约3000倍,达到30.1μg/mL;对铜绿假单胞菌(Pseudomonas aeruginosa)、大肠杆菌(Escherichia coli)和鼠沙门氏菌(Salmonella ratus)等革兰氏阴性菌的抑菌IC 50降低3~6倍,对革兰氏阳性菌中的金黄色葡萄球菌(Staphylococcus aureus)抑菌IC 50降低2倍.结果表明,Cur-Sa-Arg可极大改善姜黄素水中溶解度,并且具有更优的抗菌性. L-arginine based curcumin derivative with a succinic acid linker(Cur-Sa-Arg)was synthesized via esterification and amidation reaction using 4-dimethylaminopyridine(DMAP)and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide(EDC)as catalyzer.The product was characterized by UV-Vis,FT-IR,1H NMR and DSC,and the results indicated that Cur-Sa-Arg was successfully synthesized.The curcumin solubility in Cur-Sa-Arg was more than about 3000 times higher than curcumin and reached up to 30.1μg/mL.Moreover,the result of bacteriostatic experiment showed that the IC 50 values against Gram-negative bacteria including Pseudomonas aeruginosa,Escherichia coli and Salmonella ratus decreased by 3—6 times,and the IC 50 value against Gram-positive bacteria of Staphylococcus aureus dropped by 2 times.Compared with pure curcumin,Cur-Sa-Arg has a higher solubility and better antibacterial properties.
作者 李海鹰 邱明恒 陈健 王桂静 杨文智 LI Haiying;QIU Mingheng;CHEN Jian;WANG Guijing;YANG Wenzhi(Institute of Life Science and Green Development,College of Pharmacy,Hebei University,Baoding 071002,China)
机构地区 河北大学药学院
出处 《河北大学学报(自然科学版)》 CAS 北大核心 2021年第2期155-160,共6页 Journal of Hebei University(Natural Science Edition)
基金 河北省自然科学基金资助项目(H2018201045) 河北省高等学校科学技术研究项目(ZD2018054)
关键词 姜黄素 L-精氨酸 化学接枝 溶解度 体外抗菌 curcumin L-arginine chemical grafting solubility antibacterial activity in vitro
  • 相关文献

参考文献2

二级参考文献14

  • 1ANAND P, THOMAS S G; KUNNUMAKKARA A B, et al. Biological activities of curcumin and its analogues (congeners) made by man and mother nature[J]. Biochem Pharmacol, 2008, 76(11):1590-1611.
  • 2SARTORE L, CALICETI P, SCHIAVON O, et al. Enzyme modification by MPEG with an amino acid or peptide as space arms [J]. Appl Biochem Biotechnol, 1991, 27: 45-54.
  • 3SCHIAVON O, PASUT G, MORO S, et al. PEG-Ara-C conjugates for controlled release [J]. Eur J Med Chem, 2004, 39:123-133.
  • 4GREENWALD R B, PENDRI A, BOLIKAL D. Highly water soluble taxol derivatives: 7-polyethylene glycol carbamates and carbonates [J]. JOrg Chem, 1995, 60:331-336.
  • 5KURIEN B T, SINGH A, MATSUMOTO H, et al. Improving the solubility and pharmacolo-gical efficacy of curcumin by heat treatment [J]. Assay. Drug Dev Technol, 2007, 5(4): 567- 576.
  • 6TOMLIINSON R, HELLER J, BROCCHINI S, et al. Polyacetal-doxorubicin conjugates designed for pH-dependent degradation [J]. Bioconjug Chem, 2003, 14(6): 1096-1106.
  • 7SHARMA R A, GESCHER A J, STEWARD W P. Curcumin: the story so far [J]. EurJCancer, 2005, 41(13):1955-1968.
  • 8GREENWALD R B, CHOE Y H, MCGUIRE J, et al. Effective drug delivery by PEGylated drug conjugates [J]. Adv Drug Deliv Rev, 2003, 10, 55(2):217-250.
  • 9GREENWALD R B, CONOVER C D, CHOE Y H. Poly (ethylene glycol) conjugated drugs and prodrugs: a comprehensive review [J]. Crit Rev Ther Drug Carrier Syst, 2000, 17(2): 101- 161.
  • 10白文莉,张树云,郭菊玲,吴丽萍.比色法测定姜黄中有效成分的含量[J].中国药事,2007,21(10):840-841. 被引量:6

共引文献11

同被引文献72

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部